ASPIRE BIOPHARMA HOLDINGS, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $1.3M
Liabilities Breakdown FY2025
Total Liabilities: $7.7M
Asset Breakdown
Total Assets: $1.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.0M | 76.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $253.2K | 19.3% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $55.1K | 4.2% |
Liabilities Breakdown
Total Liabilities: $7.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.0M | 13.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $6.7M | 86.8% |